13 May - 14 May 2024
Organised by:
SCI’s Fine Chemicals Group and RSC’s Biological and Medicinal Chemistry Sector
Francis Crick Institute, London, UK
With the ever-growing prevalence of drug-resistant pathogens, it has never been more important that we refresh the drug pipeline with new antimicrobials that act on new targets or exhibit novel modes of action. The recent COVID pandemic has served to highlight the importance of developing effective treatments for infection, driving the recent resurgence in anti-infectives drug discovery and development of innovative technologies and approaches for combating infection through more effective detection and diagnosis methods.
This two-day symposium will examine the latest advances in anti-infectives drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing anti-infectives whilst also showcasing emerging strategies for tackling infection.
This meeting will bring together leading exponents in the field from academia and industry, so will appeal to anyone with an interest in antimicrobial resistance and anti-infectives drug discovery.
The full programme will be confirmed in due course.
SCI’s Fine Chemicals Group are committed to promoting diversity and equality in the chemical sciences. We aim to identify high quality speakers for all our conferences with full inclusivity where attendees from all backgrounds are welcome. We are open to offering flexible presentation options.
Francis Crick Institute
1 Midland Rd
London
NW1 1AT
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org